References
- Veliz I, Loo Y, Castillo O, Karachaliou N, Nigro O, Rosell R. Advances and challenges in the molecular biology and treatment of glioblastoma-is there any hope for the future? Ann Transl Med. 2015;3(1):7. doi:10.3978/j.issn.2305-5839.2014.10.0625705639
- Ohgaki H, Dessen P, Jourde B, et al. Genetic pathways to glioblastoma: a population-based study. Cancer Res. 2004;64(19):6892–6899. doi:10.1158/0008-5472.CAN-04-133715466178
- Daniels LB, Shaya M, Nordberg ML, Shorter CD, Fowler M, Nanda A. Glioblastoma multiforme in two non-nuclear family members. J La State Med Soc. 2007;159(4):215–222.17987960
- Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ. Neurofibromatosis type 1. Nat Rev Dis Primers. 2017;3:17004. doi:10.1038/nrdp.2017.428230061
- Wimmer K, Kratz CP, Vasen HFA, et al. Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium ‘care for CMMRD’ (C4CMMRD). J Med Genet. 2014;51(6):355–365. doi:10.1136/jmedgenet-2014-10228424737826
- Schiffman JD, Chun N, Fisher PG, Dahl GV, Ford JM, Eggerding FA. Identification of a novel p53 in-frame deletion in a Li-Fraumeni-like family. Pediatr Blood Cancer. 2008;50(4):914–916. doi:10.1002/pbc.2124717554785
- Chan AK, Han SJ, Choy W, et al. Familial melanoma-astrocytoma syndrome: synchronous diffuse astrocytoma and pleomorphic xanthoastrocytoma in a patient with germline CDKN2A/B deletion and a significant family history. Clin Neuropathol. 2017;36(5):213–221. doi:10.5414/NP30102228699883
- Ugonabo I, Bassily N, Beier A, et al. Familial glioblastoma: A case report of glioblastoma in two brothers and review of literature. Surg Neurol Int. 2011;2:153. doi:10.4103/2152-7806.86833.22140638
- Heuch I, Blom GP. Glioblastoma multiforme in three family members, including a case of true multicentricity. J Neurol. 1986;233(3):142–144.3014072
- Hardman PD, Bell J, Whittle IR, Gregor A. Familial glioma: a report of glioblastoma in identical twins and oligo-astrocytoma in siblings. Br J Neurosurg. 1989;3(6):709–715.2697216
- Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–820. doi:10.1007/s00401-016-1545-127157931
- De Carlo E, Gerratana L, De Maglio G, et al. Defining a prognostic score based on O6-methylguanine-DNA methyltransferase cut-off methylation level determined by pyrosequencing in patients with glioblastoma multiforme. J Neurooncol. 2018;140(3):559–568. doi:10.1007/s11060-018-2981-730132165
- Groll M, Frenzel J, Krause M, et al. MALDI-TOF mass spectrometric analysis of brain tumor cyst fluid reveals a protein peak corresponding to ApoC1 and LuzP6. Ojmn. 2018;08(03):251–263. doi:10.4236/ojmn.2018.83021
- Zuber MA, Krupp W, Holland H, Froster UG. Characterization of chromosomal aberrations in a case of glioblastoma multiforme combining cytogenetic and molecular cytogenetic techniques. Cancer Genet Cytogenet. 2002;138(2):111–115.12505254
- Holland H, Koschny T, Ahnert P, Meixensberger J, Koschny R. WHO grade-specific comparative genomic hybridization pattern of astrocytoma - a meta-analysis. Pathol Res Pract. 2010;206(10):663–668. doi:10.1016/j.prp.2010.04.00220570053
- Jesionek-Kupnicka D, Szybka M, Potemski P, et al. Association of loss of heterozygosity with shorter survival in primary glioblastoma patients. Pol J Pathol. 2013;64(4):268–275.24375041
- McLendon R, Friedman A, Bigner D, et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455(7216):1061–1068. doi:10.1038/nature0738518772890
- Bigner SH, Friedman HS, Biegel JA, et al. Specific chromosomal abnormalities characterize four established cell lines derived from malignant human gliomas. Acta Neuropathol. 1986;72(1):86–97.2881426
- Dahlback H-S-S, Brandal P, Meling TR, Gorunova L, Scheie D, Heim S. Genomic aberrations in 80 cases of primary glioblastoma multiforme: pathogenetic heterogeneity and putative cytogenetic pathways. Genes Chromosomes Cancer. 2009;48(10):908–924. doi:10.1002/gcc.2069019603525